These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15193462)

  • 1. High follicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment.
    van Rooij IA; de Jong E; Broekmans FJ; Looman CW; Habbema JD; te Velde ER
    Fertil Steril; 2004 Jun; 81(6):1478-85. PubMed ID: 15193462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio >or= 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles.
    Liu KE; Greenblatt EM
    Fertil Steril; 2008 Aug; 90(2):297-301. PubMed ID: 18023434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve.
    Abdalla H; Thum MY
    Hum Reprod; 2004 Apr; 19(4):893-8. PubMed ID: 15016786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization.
    Luna M; Grunfeld L; Mukherjee T; Sandler B; Copperman AB
    Fertil Steril; 2007 Apr; 87(4):782-7. PubMed ID: 17207802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
    Schachter M; Friedler S; Ron-El R; Zimmerman AL; Strassburger D; Bern O; Raziel A
    Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimulating hormone.
    Scott RT; Elkind-Hirsch KE; Styne-Gross A; Miller KA; Frattarelli JL
    Fertil Steril; 2008 Apr; 89(4):868-78. PubMed ID: 17603049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated follicle-stimulating hormone levels and the chances for azoospermic men to become fathers after retrieval of elongated spermatids from cryopreserved testicular tissue.
    Zitzmann M; Nordhoff V; von Schönfeld V; Nordsiek-Mengede A; Kliesch S; Schüring AN; Luetjens CM; Kamischke A; Cooper T; Simoni M; Nieschlag E
    Fertil Steril; 2006 Aug; 86(2):339-47. PubMed ID: 16753155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization.
    Roberts JE; Spandorfer S; Fasouliotis SJ; Kashyap S; Rosenwaks Z
    Fertil Steril; 2005 Jan; 83(1):37-41. PubMed ID: 15652884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value and clinical impact of Basal follicle-stimulating hormone in subfertile, ovulatory women.
    van der Steeg JW; Steures P; Eijkemans MJ; Habbema JD; Hompes PG; Broekmans FJ; Bouckaert PX; Bossuyt PM; van der Veen F; Mol BW
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2163-8. PubMed ID: 17405849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated testing of basal FSH levels has no predictive value for IVF outcome in women with elevated basal FSH.
    Abdalla H; Thum MY
    Hum Reprod; 2006 Jan; 21(1):171-4. PubMed ID: 16155077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening.
    Jain T; Soules MR; Collins JA
    Fertil Steril; 2004 Jul; 82(1):180-5. PubMed ID: 15237009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles.
    Klinkert ER; Broekmans FJ; Looman CW; Te Velde ER
    Fertil Steril; 2004 May; 81(5):1247-53. PubMed ID: 15136085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the follicle-stimulating hormone (FSH) threshold for initiating the final stages of follicular development in women with elevated FSH levels in the early follicular phase.
    de Koning CH; Schoemaker J; Lambalk CB
    Fertil Steril; 2004 Sep; 82(3):650-3. PubMed ID: 15374709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicle-stimulating hormone and estradiol levels independently predict the success of assisted reproductive technology treatment.
    Frazier LM; Grainger DA; Schieve LA; Toner JP
    Fertil Steril; 2004 Oct; 82(4):834-40. PubMed ID: 15482756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between women's age and basal follicle-stimulating hormone levels with aneuploidy risk in in vitro fertilization treatment.
    Thum MY; Abdalla HI; Taylor D
    Fertil Steril; 2008 Aug; 90(2):315-21. PubMed ID: 17953958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimüllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: a follow-up study.
    Yarde F; Voorhuis M; Dólleman M; Knauff EA; Eijkemans MJ; Broekmans FJ
    Fertil Steril; 2013 Sep; 100(3):831-8. PubMed ID: 23755952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.